Tarsus Pharmaceuticals, INC 8-K filings

NASDAQ
Tarsus Pharmaceuticals' Chief Medical Officer, Jose Trevejo, M.D., Ph.D., will depart from his role effective January 18, 2024, and his employment on February 17, 2024.